Seuraa
William L. Berry
William L. Berry
Muut nimetWilliam Berry
University of Oklahoma Health Sciences Center
Vahvistettu sähköpostiosoite verkkotunnuksessa ouhsc.edu
Nimike
Viittaukset
Viittaukset
Vuosi
KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells
WL Berry, R Janknecht
Cancer research 73 (10), 2936-2942, 2013
4412013
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)
BN Hannafon, KJ Carpenter, WL Berry, R Janknecht, WC Dooley, ...
Molecular cancer 14, 1-13, 2015
2272015
Oncogenic features of the JMJD2A histone demethylase in breast cancer
WL Berry, S Shin, SA Lightfoot, R Janknecht
International journal of oncology 41 (5), 1701-1706, 2012
1422012
Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
N Weygant, D Qu, WL Berry, R May, P Chandrakesan, DB Owen, ...
Molecular cancer 13, 1-14, 2014
1232014
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
TD Kim, S Shin, WL Berry, S Oh, R Janknecht
Journal of cellular biochemistry 113 (4), 1368-1376, 2012
1202012
Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression
LC Bailey-Downs, JE Thorpe, BC Disch, A Bastian, PJ Hauser, T Farasyn, ...
PloS one 9 (5), e98624, 2014
942014
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
N Weygant, D Qu, R May, RM Tierney, WL Berry, L Zhao, S Agarwal, ...
Oncotarget 6 (4), 2193, 2015
922015
A PGAM5–KEAP1–Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking
GB O'Mealey, KS Plafker, WL Berry, R Janknecht, JY Chan, SM Plafker
Journal of cell science 130 (20), 3467-3480, 2017
822017
Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors
TD Kim, JR Fuchs, E Schwartz, D Abdelhamid, J Etter, WL Berry, C Li, ...
American journal of translational research 6 (3), 236, 2014
792014
PDGFRα controls the balance of stromal and adipogenic cells during adipose tissue organogenesis
C Sun, WL Berry, LE Olson
Development 144 (1), 83-94, 2017
782017
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling
JD McBride, AJ Jenkins, X Liu, B Zhang, K Lee, WL Berry, R Janknecht, ...
Journal of Investigative Dermatology 134 (6), 1725-1734, 2014
672014
Sulforaphane is a Nrf2-independent inhibitor of mitochondrial fission
GB O'Mealey, WL Berry, SM Plafker
Redox biology 11, 103-110, 2017
622017
Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Y Ge, N Weygant, D Qu, R May, WL Berry, J Yao, P Chandrakesan, ...
International journal of cancer 143 (5), 1162-1175, 2018
562018
Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase
WL Berry, TD Kim, R Janknecht
International journal of oncology 44 (4), 1341-1348, 2014
542014
Mosaic mutant analysis identifies PDGFRα/PDGFRβ as negative regulators of adipogenesis
C Sun, H Sakashita, J Kim, Z Tang, GM Upchurch, L Yao, WL Berry, ...
Cell Stem Cell 26 (5), 707-721. e5, 2020
522020
Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury
P Chandrakesan, R May, N Weygant, D Qu, WL Berry, SM Sureban, N Ali, ...
Scientific reports 6 (1), 37667, 2016
462016
Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism
N Ali, H Allam, T Bader, R May, KM Basalingappa, WL Berry, ...
PloS one 8 (11), e80304, 2013
432013
Overexpression of DCLK1-AL increases tumor cell invasion, drug resistance, and KRAS activation and can be targeted to inhibit tumorigenesis in pancreatic cancer
D Qu, N Weygant, J Yao, P Chandrakesan, WL Berry, R May, K Pitts, ...
Journal of oncology 2019, 2019
372019
STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ
C He, SC Medley, J Kim, C Sun, HR Kwon, H Sakashita, Y Pincu, L Yao, ...
Genes & Development 31 (16), 1666-1678, 2017
342017
Survival of patients with gastrointestinal cancers can be predicted by a surrogate microRNA signature for cancer stem–like cells marked by DCLK1 kinase
N Weygant, Y Ge, D Qu, JS Kaddis, WL Berry, R May, P Chandrakesan, ...
Cancer research 76 (14), 4090-4099, 2016
332016
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20